Skip to content

Clinical trials

Phase 1/2 Neuroblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1/2 Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20032
20041
20072
20083
20093
20101
20114
20125
20131
20145
20152
20161
20171
20183
20191
20203
20214
20222
20232
20245
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting17
Terminated10
Active, not recruiting5
Unknown status4
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Baylor College of Medicine2
Children's Oncology Group2
Duke University2
Fred Hutchinson Cancer Center2
Giselle Sholler2
Hadassah Medical Organization2
Hoffmann-La Roche2
Memorial Sloan Kettering Cancer Center2
Milton S. Hershey Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma65
Osteosarcoma15
Rhabdomyosarcoma14
Sarcoma, Ewing13
Recurrence12
Sarcoma12
Medulloblastoma11
Lymphoma9
Wilms Tumor8
Ovarian Neoplasms7

Trials

Showing 76 to 65 of 65. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.